The prevention and treatment of cancer and infectious diseases requires vaccines that can mediate cytotoxic T lymphocyte-based immunity. A promising strategy is protein subunit vaccines composed of purified protein antigens and immunostimulatory adjuvants, such as Toll-like receptor (TLR) agonists. In this research, we developed two new biodegradable polymeric delivery vehicles for protein antigens and TLR agonists, as model vaccine delivery systems. This work was guided by the central hypothesis that an effective vaccine delivery system would have stimulus-responsive degradation and release, biodegradability into excretable non-acidic degradation products, and the ability to incorporate various TLR-inducing adjuvants. The first vaccine delivery system is a cross-linked polyion complex micelle which efficiently encapsulates proteins, DNA, and RNA. The micelle-based delivery system consists of a block copolymer of poly(ethylene glycol) (PEG) and poly(L-lysine), cross-linked by dithiopyridyl side groups to provide transport stability and intracellular release. The second delivery system consists of solid biodegradable microparticles encapsulating proteins, nucleic acids, and hydrophobic compounds. The microparticles are composed of pH-sensitive polyketals, which are a new family of hydrophobic, linear polymers containing backbone ketal linkages. Polyketals are synthesized via a new polymerization method based on the acetal exchange reaction and degrade into non-acidic, excretable degradation products. In addition, the technique of hydrophobic ion pairing was utilized to enhance the encapsulation of ovalbumin, DNA, and RNA in polyketal microparticles via a single emulsion method. Using in vitro and in vivo immunological models, we demonstrated that the micelle- and polyketal-based vaccine delivery systems enhanced the cross-priming of cytotoxic T lymphocytes. The model vaccines were composed of ovalbumin antigen and various TLR-inducing adjuvants including CpG-DNA, monophosphoryl lipid A, and dsRNA. The results demonstrate that the cross-linked micelles and polyketal microparticles have considerable potential as delivery systems for protein-based vaccines.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Burgers subjected to lipid reformulation were made by replacing 50% of the fat component by microparticles containing chia (CO) and linseed (LO) oils obtained by external ionic gelation. The microparticles presented high n−3 PUFAs levels and were resistant to the pH and temperature conditions commonly used in burger processing. The lipid reformulation did not affect hardness and improved important technological properties, such as cooking loss and fat retention. In addition to reducing the fat content of burgers by up to 50%, the lipid reformulation led to healthier PUFA/SFA and n−6/n−3 ratios, and lower atherogenicity and thrombogenicity indices. The burgers with CO microparticles showed a higher lipid oxidation and a lower sensory quality compared to the other treatments. However, the substitution of pork back fat by LO microparticles did not impair the sensory quality of burgers. Therefore, the microencapsulation of n−3 PUFA-rich oils by external ionic gelation can be considered an effective strategy to produce healthier burgers. / Hambúrgueres com uma reformulação lipídica foram produzidos através da substituição de 50% do seu teor de gordura por óleos de chia (CO) e de linhaça (LO) microencapsulados por gelificação iônica externa. As microcápsulas apresentaram altos teores de n-3 PUFAS e foram resistentes às condições de pH e temperatura comumente aplicadas durante o processamento de hambúrgueres. A reformulação lipídica não afetou a dureza e melhorou importantes atributos tecnológicos, como a perda no rendimento e a retenção de gordura. Além de reduzir em até 50% o teor de gordura dos hambúrgueres, a reformulação lipídica tornou mais saudável a relação PUFA/SFA e n-6/n-3 e os índices de aterogenicidade e trombogenicidade. Os hambúrgueres com CO microencapsulado apresentaram uma maior oxidação lipídica e uma menor qualidade sensorial. Por outro lado, a substituição de toucinho por LO microencapsulado não prejudicou a qualidade sensorial dos hambúrgueres. Pode-se concluir que a microencapsulação por gelificação iônica externa de óleos ricos em n-3 PUFAs pode ser considerada uma estratégia eficaz para produzir hambúrgueres com características mais saudáveis.

Made available in DSpace on 2014-12-17T15:01:17Z (GMT). No. of bitstreams: 1 BentoPCN.pdf: 1568863 bytes, checksum: bd484a66a36dd1be9ccc75015b40e5e8 (MD5) Previous issue date: 2009-03-05 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Currently, studies in the area of polymeric microcapsules and nanocapsules and controlled release are considerably advanced. This work aims the study and development of microcapsules and nanocapsules from Chitosan/MDI, using a new technique of interfacial polycondensation combined to spontaneous emulsification, for encapsulation of BZ-3. It was firstly elaborated an experimental design of 23 of the particle in white without the presence of BZ-3 and Miglyol, where the variables were the concentrations of MDI, chitosan and solvent. Starting from the data supplied by the experimental design was chosen the experiment with smaller particle diameter and only added like this BZ-3 and Miglyol. The suspension containing concentrations of 6.25 mg/mL, 12.5 mg/mL, 18.75 mg/mL, 25 mg/mL of BZ-3 were prepared, nevertheless, during the storage time, these formulations presented drug precipitates in the suspensions of 18.75 mg/mL and 25 mg/mL of BZ-3. This apparition of precipitate was attributed to the diffusion of BZ-3 for the aqueous phase without any encapsulation, suggesting so the use of the smaller concentrations of the BZ-3. The suspension containing 6.25mg/mL of BZ3 presented average size of 1.47μm, zeta potential of 61 mV, pH 5.64 and this sample showed an amount of BZ-3 and drug entrapment of 100 %. The suspension containing 12.5mg/mL of BZ-3 presented average size of 1.76μm, zeta potential of 47.4 mV, pH 5.71 and this sample showed an amount of BZ-3 and drug entrapment of 100 %. Then, showing such important characteristics, these two formulations were chosen for futher continuity to the study. These formulations were also characterized by the morphology, FTIR, stability for Turbiscan, DSC and a study of controlled release of the BZ-3 was elaborated in different receiving means / O presente trabalho visou o estudo e desenvolvimento de um sistema micro e nanoestruturado de quitosana reticulada por diisocianato, pela t?cnica de policondensa??o interfacial combinada com emulsifica??o espont?nea, para encapsula??o de benzofenona-3 (BZ-3), um filtro solar qu?mico. Foi elaborado primeiramente um planejamento experimental de 23 para desenvolvimento da formula??o de part?culas de quitosana e MDI (4,4 -difenil metano diisocianato), onde as vari?veis foram ?s concentra??es de MDI, de quitosana e do solvente. A partir dos dados fornecidos pelo planejamento experimental, optou-se pelas condi??es de processo e formula??o capazes de gerar o menor di?metro de part?cula. O estudo prosseguiu com a incorpora??o de BZ-3 e Miglyol (n?cleo das c?psulas formadas). Suspens?es de nanoc?psulas com concentra??es de 6,25 mg/mL, 12,5 mg/mL, 18,75 mg/mL e 25 mg/mL de BZ-3 foram preparadas, por?m durante o per?odo de armazenamento ocorreu o aparecimento de precipitados cristalinos, nas suspens?es de 18,75 mg/mL e 25 mg/mL de BZ-3. Este aparecimento de precipitados cristalinos foi atribu?do ? difus?o da BZ-3 para a fase aquosa n?o ocorrendo sua encapsula??o. A suspens?o contendo 6,25 mg/mL de BZ-3 apresentou di?metro m?dio de 1,47μm, potencial zeta de 61 mV, pH de 5,64 e teor de encapsula??o pr?ximos a 100 %. A suspens?o contendo 12,5mg/mL de BZ-3 apresentou di?metro m?dio de 1,76μm, potencial zeta de 47,4mV, pH 5,71 e teor de encapsula??o pr?ximos a 100 % e foi selecionada juntamente com a de 6,25 mg/mL para a continuidade do estudo. Estas formula??es foram caracterizadas tamb?m pela morfologia, turbidimetria, espectroscopia de absor??o na regi?o do infravermelho, DSC e foi elaborado um estudo de libera??o controlada do f?rmaco em diferentes meios receptores. Em conclus?o, o conjunto dos resultados obtidos demonstra que estas formula??es s?o sistemas promissores para a aplica??o cut?nea de filtros solares

Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico / The minimal processing of fruits and vegetables offers the consumer food fresh and practicality. However, these products rapidly lose quality after processing due to physical changes and their consequential biochemical reactions that can reduce the nutritional value and favours besides the growth of deteriorant and pathogenic microorganisms. Thus, this study aimed to develop a system of active packaging, consisting of an microencapsulated antimicrobial edible coating using chitosan added with bioactive compounds extracted from byproducts of processing of acerola (Malpighia emarginata D.C.) for minimally processed melon to maintain the quality and microbiological safety of this product. The parameters extraction of bioactive compounds of lyophilized byproducts (seed, peel and fibers) were optimized as the rotation speed, extraction time, extraction solution and by proportion: extraction solution. The extract showed high content of antioxidants, especially polyphenols. The coating was produced from the 1:1 mixture (v / v) solution of chitosan and 1% ethanolic extract of bioactive compounds, and chitosan itself as the encapsulating material. Two treatments (coated and uncoated melons) each 3 days during 12 days of storage at 10˚C  1 were evaluated as attributes of quality, bioactive compounds, total antioxidant activity, spoilage and pathogenic microorganisms (Salmonella spp and Listeria monocytogenes). The results showed that the coating samples provided the melons minor loss of firmness and weight, increased the content of yellow flavonoids and total extractable polyphenols, consequently high total antioxidant activity when compared to control cubes. Moreover, the coating showed antimicrobial activity against bacteria (mesophilic, psicotrophic and lactic), molds and yeasts in coated fruits. The novel product is according to RDC ANVISA 12˚ whose recommendation for fresh fruits must be absence of Salmonella spp in 25 g. Therefore, this coating is a viable alternative for maintain the quality of minimally processed melons , since it provided better nutrition by maintaining bioactive fruit compounds, the safety, beyond the scope of the life of the product. / O processamento mÃnimo de frutas e hortaliÃas oferece ao consumidor alimentos frescos e prÃticos. Contudo, estes produtos perdem rapidamente a qualidade apÃs o processamento devido Ãs alteraÃÃes fÃsicas e suas conseqÃentes reaÃÃes bioquÃmicas reduzindo o valor nutricional, alÃm de favorecer o crescimento de microrganismos patogÃnicos. Assim, este trabalho objetivou desenvolver um sistema de embalagem ativa, consistindo de um revestimento comestÃvel antimicrobiano para revestimento de melÃo minimamente processado à base de quitosana incorporado de compostos bioativos microencapsulados extraÃdos de subprodutos do processamento de acerola (Malpighia emarginata D.C) visando a manutenÃÃo da qualidade e seguranÃa microbiolÃgica do produto. Os parÃmetros de extraÃÃo dos compostos bioativos dos subprodutos liofilizados (semente, pelÃcula e fibras) foram otimizados quanto a velocidade de rotaÃÃo, tempo de extraÃÃo, soluÃÃo extratora e proporÃÃo subprodutos : soluÃÃo extratora . O extrato apresentou alto teor de compostos antioxidantes, principalmente polifenÃis. O revestimento utilizado nesse estudo foi produzido a partir da mistura na proporÃÃo 1:1 (v/v) de soluÃÃo de quitosana 1% e extrato etanÃlico de compostos bioativos, tendo a prÃpria quitosana como material encapsulante. Dois tratamentos (melÃes revestidos e nÃo revestidos) foram avaliados a cada 3 dias durante 12 dias de armazenamento a 10˚C  1 quanto aos atributos de qualidade, compostos bioativos, atividade antioxidante total, microorganismos deteriorantes e patogÃnicos (Salmonella spp e Listeria monocytogenes). Os resultados demonstraram que o revestimento proporcionou aos melÃes menor perda de firmeza e de peso, alÃm de maiores conteÃdos de flavonÃides amarelos e de polifenÃis extraÃveis totais, consequentemente elevada atividade antioxidante total quando comparado ao controle. Foi obsevado aÃÃo antimicrobiana contra bactÃrias (mesÃfilas, psicotrÃficas e lÃticas), bolores e leveduras nos frutos revestidos. O produto apresentou-se em conformidade com a RDC n˚ 12 da ANVISA cuja recomendaÃÃo para frutas in natura à de ausÃncia de Salmonela spp em 25 g. Portanto, este revestimento à uma alternativa viÃvel para a manutenÃÃo da qualidade de melÃes minimamente processados, uma vez que proporcionou a melhoria nutricional, atravÃs da manutenÃÃo de compostos bioativos da fruta a seguranÃa, alÃm da extensÃo da vida Ãtil desse produto.

Os compostos antioxidantes naturais têm sido cada vez mais investigados devido à necessidade das indústrias alimentícias suprirem as exigências dos consumidores em relação à saudabilidade dos produtos. A quercetina é um flavonoide cujos benefícios estão relacionados principalmente à sua ação antioxidante. Entretando, tal molécula apresenta, geralmente, baixa absorção no trato gastrointenstinal, o que pode ser um obstáculo para sua efetiva ação biológica. Por este motivo, uma alternativa para melhorar a sua bioacessibilidade é a encapsulação em sistemas coloidais baseados em matrizes lipídicas, como os lipossomas. Os lipossomas possuem a capacidade de incorporar tanto bioativos hidrofílicos quanto hidrofóbicos em sua estrutura, bem como proporcionar liberação controlada e aumentar a bioacessibilidade dos ingredientes encapsulados. No entanto, há necessidade do desenvolvimento de processos de produção de lipossomas em maior escala, e dentre os processos possíveis a serem empregados com este objetivo encontra-se o método de produção de injeção de etanol. O objetivo principal da presente Tese foi a microencapsulação de quercetina em lipossomas através do método de injeção de etanol. A dispersão de lipossomas encapsulando quercetina escolhida foi liofilizada, com a intenção de aumentar a estabilidade dos lipossomas e enriquecer o amido de milho. O enriquecimento do amido de milho foi realizado por aglomeração, especificamente pelo método de alto cisalhamento, sendo que o pó alimentício aglomerado resultante foi caracterizado fisicamente e teve suas propriedades físicas melhoradas. Foi possível realizar a aplicação do amido de milho enriquecido com quercetina no antepasto de berinjela, sendo que tal incorporação não alterou significativamente as características do produto. Além disso, o antepasto de berinjela foi processado a alta pressão hidrostática e teve sua estabilidade avaliada, sendo que a utilização do processamento não-térmico apresentou vantagens em relação ao método de processamento convencional. / The natural antioxidant compounds have been increasingly investigated due to the need of the food industry to provide healthier products. Quercetin is a flavonoid, whose benefits are linked mainly with its antioxidant activity. However, this bioactive generally has a low absorption rate in the gastrointestinal tract, which it can be an obstacle for its biological action effective. For this reason, an alternative to improve such bioavailability is to encapsulate quercetina in lipid-based matrices, e.g, liposomes. The liposomes have the capacity to encapsulate both hydrophilic and hydrophobic bioactive, as well as to control the release of the encapsulated bioactives, and enhance their bioavailability. However, there is a need to develop liposome production methods in larger scale, and one of the processes feasible to be scaled up is the ethanol injection method. One of the main objectives of this Thesis was to microencapsulate quercetin in liposomes by ethanol injection method. The dispersion of quercetin-loaded liposomes was lyophilized aiming to increase the stability of liposomes and enrich cornstarch. The enrichment of cornstarch was performed by agglomeration, specifically by high shear method, and the agglomerated food powders were characterized and their physical properties was improved. It was possible to incorporate the enriched cornstarch with quercetin in eggplant sauce, and such application did not change the product characteristics. Also, the eggplant sauce was processed by high hydrostatic pressure and had its stability evaluated, indicating the use of nonthermal technology showed advantages if compared to the conventional thermal processing.

La nécessité de nouveaux modes de suppléance hépatique se fait clairement ressentir pour maintenir en vie les patients en attente d’une greffe. Des traitements, basés sur l’utilisation de cellules cultivées dans un environnement adéquat, pourraient même permettre le rétablissement de certains patients en insuffisance hépatique sévère et ainsi éviter la greffe et les traitements immunosuppresseurs associés. Une suppléance hépatique efficace pourrait aussi servir au rétablissement des patients récemment greffés ou ayant subi une hépatectomie. L’objectif de cette thèse a été de développer, créer et valider un nouveau foie bioartificiel avec une prise en compte des contraintes réglementaires des médicaments combinés de thérapie innovante. Ce BAL doit pouvoir inclure des bioréacteurs à lit fluidisé perfusés par du plasma et contenant des sphéroïdes d’hépatocytes encapsulés. Des microparticules de verre, ajoutés aux billes d’alginate pour les alourdir, permettent d’obtenir une fluidisation optimale dans du plasma pathologique sans que des effets délétères ne soient observables ni pour les cellules ni pour les propriétés mécaniques des billes. Une méthode de culture cellulaire utilisant un revêtement anti-adhérent sur des boites de Petri en verre permet de produire un nombre important de sphéroïdes viables in vitro. Ces sphéroïdes encapsulés peuvent être maintenus vivants et métaboliquement actifs dans un bioréacteur à lit fluidisé pendant au minimum 4 jours.Pour assurer l’efficacité du BAL et la sécurité des patients, une circulation extracorporelle complexe a été mise au point pour être compatible avec une machine d’épuration extracorporelle commerciale, la Prismaflex® de la société Gambro, déjà utilisée en soins intensifs. Une étude préclinique sur un modèle ovin a montré que le traitement était bien toléré en ce qui concerne les aspects hémodynamiques. La prochaine étape concerne la mise en place d’une étude dans un modèle porcin d’insuffisance hépatique, avant de pouvoir procéder aux premiers essais cliniques. / The need for new liver support devices is clearly felt to allow keeping alive patients waiting for a transplant. Treatments, based on the use of cells cultured in an adequate environment, may even allow the recovery of some patients suffering from acute liver failure and avoid graft and associated immunosuppressive therapies. A hepatic substitution could also be used to reestablish patients recently transplanted or who had underwent an hepatectomy.. The objective of the thesis was to design, create and validate of a new bioartificial liver with consideration for the regulatory requirements of the Advanced Therapies Medical Product (ATMP). This device has to include fluidized bed bioreactors perfused with plasma and hosting alginate-encapsulated hepatocytes spheroids. Microparticles of glass have been added to weight down alginate beads in order to have an optimal fluidization in pathological plasma without negative effects neither on cells metabolism nor on mechanical properties of the beads. A cellular culture method using non adhesive coating in Petri dish led to the production of a large amount of viable spheroids in vitro. These encapsulated spheroids can be kept alive and metabolically active in a fluidized bed bioreactor during a minimum of four days. To ensure the efficacy of the BAL and the safety of patients, a complex extracorporeal circulation was designed to be compatible with a commercial medical device, the Prismaflex® monitor of the company Gambro, already used in intensive care units. A preclinical study on sheeps has shown that the treatment was well tolerated in terms of hemodynamics considerations. The next step is the establishment of a study in a porcine model of liver failure, before we can proceed to the first clinical trial.

Orientador: Carlos Raimundo Ferreira Grosso / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos / Made available in DSpace on 2018-08-24T10:13:53Z (GMT). No. of bitstreams: 1 Costa_BiancaSouzada_M.pdf: 3645103 bytes, checksum: ee9884c2d54163da7814b0ea032a53c5 (MD5) Previous issue date: 2014 / Resumo: O objetivo deste trabalho foi produzir partículas de pectina e alginato por gelificação iônica, com posterior recobrimento com isolado proteico de soja (IPS), gelatina de pele de tilápia (GPT) e com a mistura dessas duas proteínas (IPS:GPT), avaliando suas características físico-químicas e seu comportamento frente a diferentes tratamentos. No estudo preliminar foram analisadas as condições que promovessem a carga elétrica livre que otimizassem a interação entre os polissacarídeos e proteínas, formando complexos insolúveis. A partir desses ensaios foram estabelecidas as seguintes proporções de polissacarídeo: proteína e valores de pH: 1:2 em pH4 para recobrimento com gelatina de pele de tilápia, e 1:0,75 em pH3 para interação com o isolado proteico de soja e para a mistura das duas proteínas. Foram testados 4 níveis de proteína em solução ( 1, 2, 4 e 8 %) para recobrimento das partículas de pectina e alginato. As partículas obtidas foram caracterizadas pelo teor de umidade, conteúdo proteico adsorvido e pela sua morfologia. A partir deste estudo preliminar foi selecionada a concentração de 8% de proteína em solução, devido à produção de partículas com alto teor proteico. Estas partículas foram avaliadas com relação à sua estabilidade frente a variações de pH, diferentes concentrações de NaCl e sob simulação das condições gastrointestinais in vitro. Utilizando a concentração de 8% de proteína em solução foram obtidos altos valores de adsorção proteica, resultando no percentual de proteína de 61,87%, 47,61% e 52,06% para as partículas recobertas com GPT, IPS e IPS:GPT, respectivamente. A variação de pH e das concentrações de sal influenciaram na solubilidade da camada proteica, apresentando uma maior solubilidade em condições de extrema acidez (pH 1) e a medida em que aumentava a concentração de sal. Nas faixas de pH (1 a 7) e nas concentrações de NaCl (0 a 584 mM) estudadas, independente do valor da solubilidade proteica obtida, todas as partículas permaneceram íntegras. No ensaio gastroentérico in vitro, as partículas de pectina e alginato (PEC:ALGPart) sem recobrimento e as recobertas com gelatina de pele de tilápia (GPTPart) foram resistentes as condições gástricas e entéricas, permanecendo íntegras. As partículas recobertas com isolado proteico de soja (IPSPart) e com a mistura de proteínas (IPS:GPTPart), foram resistentes às condições gástricas, porém desintegraram-se em meio intestinal, liberando o material encapsulado / Abstract: The aim of this work was to produce particles of pectin and alginate by ionic gelation with subsequent coating with isolated soy protein (IPS), tilapia skin gelatin (GPT), and a mixture of these two proteins (IPS:GPT), evaluating their physico-chemical characteristics and behavior to different treatments. In the preliminary study, the conditions that promote the balance of free electrical charge due the interaction between polysaccharides and proteins were analyzed. From these tests the following proportions of polysaccharide:protein and pH values were established: 1:2 at pH 4 for covering with tilapia skin gelatin, and 1:0.75 at pH3 for interaction with the isolated soybean protein and mixing of the two proteins. Four protein levels were tested (1, 2, 4 and 8%) in solutions for coating the particles of pectin and alginate. The particles obtained were characterized by moisture content, adsorbed protein content and their morphology. From this preliminary study it was selected the concentration of 8% protein solution, due to the production of particles with high protein content. These particles were evaluated for their stability against pH changes, different concentrations of NaCl and simulation under the simulated gastrointestinal conditions. Using a concentration of 8% protein solution high levels of protein adsorption were obtained, resulting in percentage of protein adsorbed of 61.87%, 47.61% and 52.06% for the coated particles GPT, IPS and IPS: GPT, respectively. The variation of pH and salt concentrations influence the solubility of the protein layer having a higher solubility in conditions of extreme acidity (pH 1) and the extent to which increased salt concentration. In the pH ranges and concentrations of NaCl studied, regardless of the amount of protein solubility obtained, all the particles remained intact. In the gastrointestinal assay, pectin and alginate particles (PEC: ALGPart) uncoated and coated particles with tilapia skin gelatin (GPTPart) were resistant to the gastric and enteric conditions, remaining intact. The coated particles with isolated soy protein (IPSPart) and the protein mixture (IPS:GPTPart) were resistant to gastric conditions, but disintegrated in the intestinal environment, releasing the encapsulated material / Mestrado / Nutrição Experimental e de Alimentos / Mestra em Alimentos e Nutrição

O transplante de ilhotas microencapsuladas constitui uma alternativa terapêutica interessante para o Diabetes Mellitus tipo 1, permitindo um melhor controle glicêmico e eliminando a necessidade de imunossupressão. Entretanto, a manutenção a longo prazo da viabilidade das células-&#946; ainda é um desafio. No isolamento, a perda da matriz extracelular e as condições hipóxicas subsequentes afetam decisivamente a sobrevivência e funcionalidade das ilhotas. Objetivo Para diminuir o estresse sobre o enxerto, levando a um sucesso prolongado do transplante, propôs-se a adição de perfluorocarbono (PFC) ou laminina (LN), moléculas associadas respectivamente à oxigenação e interações célula-célula, ao biomaterial baseado em alginato, Biodritina, adequado ao encapsulamento celular. Metodologia Para testar a estabilidade das formulações PFC-Biodritina e LN-Biodritina, microcápsulas foram submetidas a diferentes estresses (rotacional, osmótico, temperatura e cultura) por 7 e 30 dias. A pureza do biomaterial foi avaliada pela coincubação com macrófagos murinos RAW264.7, por 3, 9 e 24h, quando a ativação dos macrófagos foi observada pela expressão gênica de IL- 1&#946; e TNF&#945;. Microcápsulas implantadas i.p. em camundongos foram recuperadas após 7 ou 30 dias, para análises de biocompatibilidade. A expressão de níveis de mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulina 1 e 2), proteínas (Bax, Bcl-XL e Xiap) e a atividade de Caspase3 foram avaliadas em ilhotas microencapsuladas com PFC- e LN-Biodritina, após cultura de 48h em condições de normóxia e hipóxia (<2% O2). Camundongos diabéticos foram transplantados com ilhotas encapsuladas nas diferentes formulações e os animais foram monitorados pelas variações de massa corporal, glicêmicas e pela funcionalidade do enxerto (TOTGs). As ilhotas foram recuperadas de animais normo ou hiperglicêmicos e uma análise de biocompatibilidade das cápsulas foi realizada, assim como a avaliação funcional das células-&#946;. Após o explante, a glicemia dos animais normoglicêmicos foi monitorada para se atestar a eficiência das ilhotas transplantadas. Resultados Microcápsulas de PFC- e LN-Biodritina são tão estáveis e biocompatíveis quanto as de Biodritina. Para ilhotas encapsuladas em ambos os materiais, em normóxia ou hipóxia, observou-se uma modulação gênica que sugere proteção contra apoptose. Adicionalmente, encontrou-se uma diminuição na expressão de genes indicadores de estresse (mcp1, hsp70). Uma diminuição nos níveis de mRNA de ldh foi vista para PFC-Biodritina, mas o oposto foi encontrado para LN-Biodritina. As diferenças encontradas na expressão proteica sugerem o mesmo padrão anti-apoptótico. Caspase3 não foi modulada por nenhum biomaterial. Nos experimentos de transplante, apenas LN-Biodritina levou reversão prolongada do diabetes, com 60% dos animais normoglicêmicos, 198 dias pós-cirurgia, comparado a 9% do grupo Biodritina. O TOTG demonstrou que camundongos transplantados com ilhotas encapsuladas secretaram mais insulina do que controles, 60 (LN-Biodritina) ou 100 (PFC- e LN-Biodritina) dias pós-cirurgia. O explante restabeleceu a hiperglicemia nos camundongos. Microcápsulas recuperadas de animais hiperglicêmicos apresentavam uma extensa adesão celular. Testes de secreção de insulina in vitro demonstraram que somente ilhotas do grupo normoglicêmico responderam às variações da concentração de glicose. Conclusão A adição de moléculas bioativas à Biodritina é capaz de diminuir o estresse em ilhotas isoladas e tem o potencial de melhorar a terapia pelo transplante de ilhotas. / Transplantation of microencapsulated islets represents an attractive therapeutical approach to treat type 1 Diabetes Mellitus, accounting for an improved glycemic control and the abolishment of immunosuppressive therapies. However, maintenance of long-term &#946;-cell viability remains a major problem. During islet isolation, the loss of extracellular matrix interactions and the hypoxic conditions thereafter dramatically affect &#946;-cell survival and function. Objective To lessen the burden of islet stress and achieve a better outcome in islet transplantation we tested the addition of perfluorocarbon (PFC) or laminin (LN), molecules associated respectively with oxygenation and cell-cell interaction, to Biodritin, an alginate-based material suitable for cell microencapsulation. Methodology To test the stability of PFC-Biodritin and LN-Biodritin composites, microcapsules were subjected to different stresses (rotational, osmotic, temperature and culture) for 7 and 30 days. To assess biomaterial purity microcapsules were co-incubated with RAW264.7 murine macrophage cell line for 3, 9 and 24h and macrophage activation was detected through mRNA levels of IL-1&#946; and TNF&#945;. Microcapsules were implanted i.p. in mice and retrieved after 7 or 30 days, for biocompatibility analyses. Gene expression at mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulin 1 and 2) and protein (Bax, Bcl-XL and Xiap) levels, together with Caspase3 activity, were evaluated in islets microencapsulated in PFC- or LN-Biodritin, upon culturing for 48h in normoxic or hypoxic (<2% O2) conditions. Diabetic mice were transplanted with PFC- or LN-Biodritin microencapsulated islets, followed by assessments of body weight, glycemia and graft function by oral glucose tolerance tests (OGTTs). Microencapsulated islets were retrieved from normoglycemic or hyperglycemic mice and biocompatibility analyses of the beads together with a functional assessment of the graft followed. After graft removal, normoglycemic animals had their glycemias monitored to attest the efficacy of the transplanted islets. Results PFC- and LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. For both biomaterials in normoxia and hypoxia a modulation in gene expression was observed in islets associated with a protection against apoptosis. Also, a decreased expression of stress-related genes (mcp1, hsp70) was evidenced. ldh mRNA levels were down-regulated in PFC-Biodritin microencapsulated islets but upregulated in the presence of LN. Increased levels of insulin mRNA were observed. The differences seen in protein expression indicated the same anti-apoptotic pattern. Caspase3 activity was not different between groups. Concerning diabetes reversal experiments, only mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome, with 60% remaining euglycemic at 198 days post-surgery, compared with 9% for the Biodritin group. OGTT showed that mice transplanted with encapsulated islets secreted more insulin than normal mice, 60 (LN-Biodritin) or 100 days (PFC- and LN-Biodritina) posttransplant. Hyperglycemia was achieved after the retrieval of microcapsules showing graft efficacy. Retrieved microcapsules revealed an extensive overgrowth in most beads from hyperglycemic mice. A static glucose stimulated insulin secretion test revealed that only islets from normoglycemic subjects were able to secrete insulin according to glucose concentration. Conclusion- The addition of bioactive molecules to Biodritin may lessen the stress of isolated islets and have the potential to improve islet transplantation therapy.

Bien que les résultats métaboliques de la transplantation d’îlots chez le patient diabétique de type 1 soient désormais bien démontrés, ils sont contrebalancés par les effets indésirables des traitements immunosuppresseurs et la perte de fonctionnalité du greffon à long terme.Au cours de cette thèse, nous avons étudié deux approches complémentaires offrant la perspective de s’affranchir du traitement immunosuppresseur tout en protégeant les îlots de l’apoptose et de la perte de fonctionnalité du greffon induites par les mécanismes d’isolement, de culture et de transplantation : l’immunoisolation des îlots dans des capsules de biomatériaux et la co-transplantation avec des cellules souches mésenchymateuses (CSM).Au sein du projet européen de pancréas artificiel BIOCAPAN, nous avons évalué in vitro, la biocompatibilité de différents biomatériaux et mis en évidence un effet combiné de la présence de CSM et des tripeptides RGD sur le maintien de la viabilité et de la fonctionnalité des îlots encapsulés. L’évaluation ultérieure de la biocompatibilité et de l’effet ajouté de la capsule BIOCAPAN sur des animaux diabétiques permettra la validation de la capsule qui sera proposée à des tests d’essais cliniques.Nous avons également démontré, dans un modèle de co-culture d’îlots avec des CSM dans des conditions de culture classiques et exposées à des cytokines pro-inflammatoires, que les CSM régulaient les capacités sécrétrices des îlots probablement via la régulation de l’hème oxygénase 1 (HO-1). L’identification des facteurs de transcription régulant HO-1 ainsi que des médiateurs permettant la communication entre les deux types cellulaires sont des perspectives de développement.Ce travail a souligné l’intérêt, au sein d’une approche immuno-isolante, de la reconstitution d’un environnement favorable au sein de la capsule permettant la préservation de l’îlot notamment via l’utilisation de CSM. / Although, the metabolic results of islets transplantation for patient with type 1 diabetes are now well documented, they are counteracted by the adverse effects of immunosuppressive therapies and the long-term loss in graft functionality.During this thesis, we worked on two complementary approaches offering the perspective of avoiding immunosuppressive treatment while protecting islets from apoptosis and loss of functionality induced by the mechanisms of isolation, culture and transplantation. These two tools are islet immunoisolation in capsules composed of specific biomaterials and islets co-transplantation with mesenchymal stem cells (MSCs) described for their immunomodulatory, proangiogenic and cytoprotective properties.In the european project of bioartificial pancreas BIOCAPAN, we have evaluated in vitro the biocompatibility of several biomaterials and we have highlight a combined effect of the presence of MSCs and tripeptides RGD on the viability and the functionality maintenance of the encapsulated islets. Subsequent in vivo validation of the biocompatibility and the added effect of the BIOCAPAN capsule on diabetic animals will allow the final validation of the capsule to be proposed for clinical trials.We also demonstrated, in an islet co-culture model with MSCs under conventional culture conditions and exposed to pro-inflammatory cytokines, that MSCs regulate the secretory capacity of islets probably via the regulation of heme oxygenase 1 (HO-1) described for its antioxidant and anti-inflammatory properties. The identification of transcription factors regulating HO-1 as well as mediators, allowing communication between the two cell types, are development perspectives.This work underlined the interest, within an immuno-isolation approach, of the reconstitution of a favorable environment within the capsule allowing the preservation of islet physiology thanks to the use of MSCs.

No description available.